Cambridge Investment Research Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17K Buy
31,790
+6,000
+23% +$3.21K ﹤0.01% 3584
2025
Q1
$17K Hold
25,790
﹤0.01% 3468
2024
Q4
$26K Hold
25,790
﹤0.01% 3412
2024
Q3
$22K Buy
25,790
+300
+1% +$256 ﹤0.01% 3363
2024
Q2
$9K Buy
25,490
+200
+0.8% +$71 ﹤0.01% 3295
2024
Q1
$17K Sell
25,290
-5,284
-17% -$3.55K ﹤0.01% 3271
2023
Q4
$17K Sell
30,574
-280
-0.9% -$156 ﹤0.01% 3150
2023
Q3
$19K Hold
30,854
﹤0.01% 3085
2023
Q2
$40K Hold
30,854
﹤0.01% 3098
2023
Q1
$54K Hold
30,854
﹤0.01% 3030
2022
Q4
$97K Sell
30,854
-58
-0.2% -$182 ﹤0.01% 2915
2022
Q3
$151K Hold
30,912
﹤0.01% 2781
2022
Q2
$128K Buy
30,912
+2,050
+7% +$8.49K ﹤0.01% 2824
2022
Q1
$168K Sell
28,862
-100
-0.3% -$582 ﹤0.01% 2921
2021
Q4
$217K Sell
28,962
-542
-2% -$4.06K ﹤0.01% 2817
2021
Q3
$266K Sell
29,504
-69
-0.2% -$622 ﹤0.01% 2556
2021
Q2
$354K Sell
29,573
-5,233
-15% -$62.6K ﹤0.01% 2350
2021
Q1
$436K Hold
34,806
﹤0.01% 1998
2020
Q4
$543K Buy
34,806
+4,861
+16% +$75.8K ﹤0.01% 1718
2020
Q3
$283K Sell
29,945
-100
-0.3% -$945 ﹤0.01% 1980
2020
Q2
$269K Hold
30,045
﹤0.01% 1966
2020
Q1
$191K Hold
30,045
﹤0.01% 1958
2019
Q4
$251K Buy
30,045
+7,125
+31% +$59.5K ﹤0.01% 2033
2019
Q3
$207K Buy
22,920
+3,434
+18% +$31K ﹤0.01% 2092
2019
Q2
$210K Buy
19,486
+200
+1% +$2.16K ﹤0.01% 1973
2019
Q1
$184K Buy
19,286
+2,990
+18% +$28.5K ﹤0.01% 2094
2018
Q4
$187K Buy
16,296
+5,580
+52% +$64K ﹤0.01% 1939
2018
Q3
$182K Buy
+10,716
New +$182K ﹤0.01% 2074